BACKGROUND: Hepatitis C is often asymptomatic, presenting with liver failure and cancer decades after infection. People who inject drugs (PWID) and immigrant populations from countries with a moderate-to-high prevalence of hepatitis C virus (HCV) are the main risk groups. Deaths and hospital admissions due to HCV cirrhosis tripled between 1998 and 2010, but the majority of people with chronic HCV are unaware of it. AIM: To identify patients at risk of developing hepatitis C using routine GP data, to determine the proportion not tested, and to explore GPs' views regarding testing. DESIGN AND SETTING: Mixed-methods service evaluation (density-based selection of PWID) in six NHS practices in Bristol. METHOD: Patients at risk of HCV were identified. The Health Protection Agency laboratory (now part of Public Health England) provided test results. Semi-structured interviews with 17 GPs were audiorecorded and thematic analyses conducted on anonymised transcripts. RESULTS: Of 3765 patients identified as being at risk of developing hepatitis C, 3051 (81%) had no test result, including 53% of PWID and 93% of the 'ethnicity' group. All GPs said they usually test PWID. Most GPs test for HIV and hepatitis B in immigrants more often than they test for HCV. Barriers to testing included not questioning patients about risk factors, competing priorities, the chaotic lifestyle of PWID, difficulty extracting information from computerised records, and forgetting to address HCV. CONCLUSION: Computer prompts and GP education on whom to test are warranted. Ensuring that country of origin and drug use is included on the new-patient questionnaire might also aid case-finding for HCV.
BACKGROUND: Hepatitis C is often asymptomatic, presenting with liver failure and cancer decades after infection. People who inject drugs (PWID) and immigrant populations from countries with a moderate-to-high prevalence of hepatitis C virus (HCV) are the main risk groups. Deaths and hospital admissions due to HCV cirrhosis tripled between 1998 and 2010, but the majority of people with chronic HCV are unaware of it. AIM: To identify patients at risk of developing hepatitis C using routine GP data, to determine the proportion not tested, and to explore GPs' views regarding testing. DESIGN AND SETTING: Mixed-methods service evaluation (density-based selection of PWID) in six NHS practices in Bristol. METHOD: Patients at risk of HCV were identified. The Health Protection Agency laboratory (now part of Public Health England) provided test results. Semi-structured interviews with 17 GPs were audiorecorded and thematic analyses conducted on anonymised transcripts. RESULTS: Of 3765 patients identified as being at risk of developing hepatitis C, 3051 (81%) had no test result, including 53% of PWID and 93% of the 'ethnicity' group. All GPs said they usually test PWID. Most GPs test for HIV and hepatitis B in immigrants more often than they test for HCV. Barriers to testing included not questioning patients about risk factors, competing priorities, the chaotic lifestyle of PWID, difficulty extracting information from computerised records, and forgetting to address HCV. CONCLUSION: Computer prompts and GP education on whom to test are warranted. Ensuring that country of origin and drug use is included on the new-patient questionnaire might also aid case-finding for HCV.
Entities:
Keywords:
evaluation research; hepatitis C; primary health care; screening
Authors: Matthew Hickman; Vanessa Higgins; Vivian Hope; Mark Bellis; Kate Tilling; Angeline Walker; John Henry Journal: J Epidemiol Community Health Date: 2004-09 Impact factor: 3.710
Authors: Mathew Hickman; Vivian Hope; Barbara Coleman; John Parry; Maggie Telfer; John Twigger; Charles Irish; John Macleod; Hugh Annett Journal: J Public Health (Oxf) Date: 2009-07-11 Impact factor: 2.341
Authors: Robert R Leverence; Robert L Williams; Wilson Pace; Bennett Parnes; Yvonne Fry-Johnson; Dorothy R Pathak; Betty Skipper; Elvan Daniels; Philip Kroth Journal: J Am Board Fam Med Date: 2009 Nov-Dec Impact factor: 2.657
Authors: Arthur Y Kim; Ellen H Nagami; Christopher E Birch; Melinda J Bowen; Georg M Lauer; Barbara H McGovern Journal: Hepatology Date: 2013-02-15 Impact factor: 17.425
Authors: David T Arnold; Louise M Bentham; Ruth P Jacob; Richard J Lilford; Alan J Girling Journal: BMC Fam Pract Date: 2011-03-03 Impact factor: 2.497
Authors: Lauren M K Mason; Irene K Veldhuijzen; Erika Duffell; Ayla van Ahee; Eveline M Bunge; Andrew J Amato-Gauci; Lara Tavoschi Journal: J Viral Hepat Date: 2019-08-16 Impact factor: 3.728